Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CDKN2A negative
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Associations
(5)
News
Trials
B | Sensitive
C3 | Sensitive
B | Resistant
C3 | Resistant
Show legend
Drug categories
EGFR
Tyrosine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Squamous Cell Carcinoma of Head and Neck
Mesothelioma
panitumumab
B
CDKN2A negative
|
Squamous Cell Carcinoma of Head and Neck
|
panitumumab
afatinib
B
CDKN2A negative
|
Squamous Cell Carcinoma of Head and Neck
|
afatinib
abemaciclib
C3
CDKN2A negative
|
Mesothelioma
|
abemaciclib
nivolumab + cetuximab
C3
CDKN2A negative
|
Squamous Cell Carcinoma of Head and Neck
|
nivolumab + cetuximab
everolimus
C3
CDKN2A negative
|
Squamous Cell Carcinoma of Head and Neck
|
everolimus
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
